Gene expression profiling as an initial approach for mechanistic studies of toxicity and tumorigenicity of herbal plants and herbal dietary supplements.
Dietary supplements are consumed by more than 300 million people worldwide, and herbal dietary supplements represent the most rapidly growing portion of this industry. Even though adverse health effects of many herbal dietary supplements have been reported, safety assurances are not being addressed adequately. Toxicological data on the identification of genotoxic and tumorigenic ingredients in many raw herbs are also lacking. Currently, more than 30 herbal dietary supplements and active ingredients have been selected by the National Toxicology Program (NTP) for toxicity and tumorigenicity studies. Due to the complexity of the chemical components present in plant extracts, there are no established methodologies for determining the mechanisms of toxicity (particularly tumorigenicity) induced by herbs, such as Gingko biloba leaf extract (GBE) and other herbal plant extracts. Consequently, the understanding of toxicity of herbal dietary supplements remains limited. We have proposed that application of DNA microarrays could be a highly practical initial approach for revealing biological pathways and networks associated with toxicity induced by herbal dietary supplements and the generation of hypotheses to address likely mechanisms. The changes in expression of subsets of genes of interest, such as the modulation of drug metabolizing genes, can be analyzed after treatment with an herbal dietary supplement. Although levels of gene expression do not represent fully the levels of protein activities, we propose that subsequent biochemical and genomic experiments based on these initial observations will enable elucidation of the mechanisms leading to toxicity, including tumorigenicity. This review summarizes the current practices of microarray analysis of gene expressions in animals treated with herbal dietary supplements and discusses perspectives for the proposed strategy.
Guo
Lei
L
Division of Biochemical Toxicology, National Center for Toxicological Research, Jefferson, FDA, AR 72079, USA. lei.guo@fda.hhs.gov
Mei
Nan
N
Xia
Qingsu
Q
Chen
Tao
T
Chan
Po-Chuen
PC
Fu
Peter P
PP
D002273:Carcinogens / Q000633:toxicity*; D019587:Dietary Supplements; D020869:Gene Expression Profiling; D029001:Herbal Medicine; D006801:Humans; D009153:Mutagens / Q000633:toxicity*
D002273:Carcinogens; D009153:Mutagens
J Ethnopharmacol. 1992 Aug;37(1):13-45
1453702
Toxicol Appl Pharmacol. 2007 Sep 1;223(2):114-20
17306318
Chem Biol Interact. 1999 Apr 1;118(2):151-69
10359459
Mitochondrion. 2007 Sep;7(5):322-9
17526437
Drug Metab Rev. 1994;26(1-2):165-83
8082563
Toxicol Sci. 2002 Jun;67(2):219-31
12011481
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2008 Oct-Dec;26(4):317-38
19034791
MMWR Morb Mortal Wkly Rep. 2002 Nov 29;51(47):1065-7
12500906
J Toxicol Clin Toxicol. 2003;41(2):109-13
12733846
Annu Rev Pharmacol Toxicol. 2007;47:89-116
16968214
Toxicol Sci. 2007 Jan;95(1):5-12
16963515
Toxicol Appl Pharmacol. 2004 Dec 1;201(2):85-96
15541748
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3410-5
11248092
Toxicol Sci. 2006 Feb;89(2):352-60
16221963
Toxicol Lett. 2004 Apr 15;150(1):85-96
15068826
J Toxicol Clin Toxicol. 2003;41(6):821-9
14677792
Expert Opin Drug Metab Toxicol. 2006 Dec;2(6):875-94
17125407
Drug Metab Dispos. 2003 Jul;31(7):815-32
12814957
BMC Bioinformatics. 2007 Nov 01;8 Suppl 7:S22
18047722
Gastroenterology. 1997 Oct;113(4):1408-12
9322538
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2007 Jul-Sep;25(3):211-44
17763047
Environ Mol Mutagen. 2008 Dec;49(9):741-5
18800343
Drug Metab Rev. 2003 Feb;35(1):35-98
12635815
Am J Gastroenterol. 2004 May;99(5):950-2
15128366
J Am Acad Child Adolesc Psychiatry. 2002 Jun;41(6):631-2
12049436
J Ethnopharmacol. 2005 Aug 22;100(1-2):108-13
16005588
Food Chem Toxicol. 2009 Feb;47(2):433-42
19100306
Drug Metab Rev. 2004 Feb;36(1):1-55
15072438
OMICS. 2010 Feb;14(1):75-90
20141330
Toxicol Sci. 2007 May;97(1):214-21
17329236
BMC Bioinformatics. 2006 Sep 06;7 Suppl 2:S16
17118137
Drug Metab Dispos. 2005 Oct;33(10):1446-52
15987777
Ann Intern Med. 2001 Jul 3;135(1):68-9
11434754
J Clin Pharmacol. 2008 Jun;48(6):662-70
18378963
BMC Bioinformatics. 2007 Nov 01;8 Suppl 7:S4
18047727
Drug Metab Dispos. 2002 Nov;30(11):1153-7
12386118
Toxicol Pathol. 2007 Jun;35(4):459-73
17562481
J Biol Chem. 2004 May 28;279(22):23052-60
15020583
Mol Pharmacol. 2008 Jun;73(6):1785-95
18334601
Mitochondrion. 2009 Apr;9(2):149-58
19460291
Drugs Aging. 2005;22(6):525-39
15974642
Annu Rev Pharmacol Toxicol. 2006;46:41-64
16402898
Exp Toxicol Pathol. 2007 Jan;58(4):223-36
17059882
Food Chem Toxicol. 2010 Feb;48(2):686-96
19948201
Nat Rev Genet. 2004 Dec;5(12):936-48
15573125
Drugs. 2005;65(9):1239-82
15916450
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2008 Jan-Mar;26(1):89-112
18322868
Toxicol Lett. 2001 Mar 31;120(1-3):359-68
11323195
Clin Pharmacokinet. 2000 Jun;38(6):493-504
10885586
Eur J Gastroenterol Hepatol. 2003 Sep;15(9):1033-6
12923378
Case Manager. 2002 Jul-Aug;13(4):26-8
12131903
Cancer Res. 1999 Oct 1;59(19):4759-60
10519378
Toxicol Appl Pharmacol. 2001 Aug 15;175(1):28-42
11509024
Lakartidningen. 2005 Jul 11-24;102(28-29):2071-2
16097177
Drug Metab Rev. 2007;39(2-3):419-42
17786630
Biochem Pharmacol. 2004 Feb 1;67(3):427-37
15037195
Geriatrics. 2005 Sep;60(9):24-5
16153141
Br J Cancer. 2005 Mar 14;92(5):873-5
15726100
Gastroenterol Hepatol. 2002 Jun-Jul;25(6):434-5
12069710
Drug Metab Dispos. 2007 Feb;35(2):240-5
17079360
BMC Bioinformatics. 2006 Sep 06;7 Suppl 2:S20
17118142
Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4611-6
11287661
Toxicol Ind Health. 2006 Sep;22(8):321-7
17120530